Brooks Lab Share Price

Compare

High:loading Low:loading Return: loading

High:loading Low:loading Return: loading

Max:loading Min:loading Median:loading

Max:loading Min:loading Median:loading

loading...
loading...
loading...
loading...
loading...
loading...
loading...
loading...

Stock Range

Today’s Range

Low: 45.21 High: 53.43

52 Week Range

Low: 36.30 High: 164.02

Liquidityliquidity High

Low Moderate High

Fundamentals

  • Market capMarket cap information

    ₹158 Cr

  • Revenue (TTM)Revenue (TTM) information

    ₹89 Cr

  • Net Profit (TTM)Net Profit (TTM) information

    ₹22 Cr

  • ROEROE information

    -12.2 %

  • ROCEROCE information

    -10 %

  • P/E RatioP/E Ratio information

    7.3

  • P/B RatioP/B Ratio information

    1.4

  • Industry P/EIndustry P/E information

    26.59

  • EV/EBITDAEV/EBITDA information

    17.6

  • Div. YieldDiv. Yield information

    0 %

  • Debt to EquityDebt to Equity information

    0.1

  • Book ValueBook Value information

    ₹39.4

  • EPSEPS information

    ₹7.3

  • Face valueFace value information

    10

  • Shares outstandingShares outstanding information

    29,457,248

10 Years Aggregate

CFO

₹-57.58 Cr

EBITDA

₹-40.83 Cr

Net Profit

₹-139.99 Cr

Performance

Company
YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Brooks Lab
-33.4 -20.5 -31.2 -51.8 -4.7 -2.2 -2.9
BSE Healthcare
-4.7 -5.8 -5.4 1.3 23.7 14.0 10.6
As on 02-Apr-2026
Company
2025
2024
2023
2022
2021
2020
2019
Brooks Lab
-56.4 23.4 32.6 8.9 43.9 170.4 -51.6
BSE Small Cap
-6.6 29.0 47.5 -1.8 62.8 32.1 -6.8
BSE Healthcare
-3.3 43.1 37.0 -12.1 20.9 61.4 -3.5

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details
loading...

*All values are in (₹ Cr)

loading...

*All values are in (₹ Cr)

loading...

*All values are in (₹ Cr)

Key Ratios

View Details
loading...

loading...

loading...

5Y Avg -- 3Y Avg -- TTM --

loading...

P/E Ratio

--

--Min --Median --Max

loading...

P/B Ratio

--

--Min --Median --Max

loading...

Earnings Yield (%)

--

Earnings Yield (%) = EBIT / Enterprise value

PEG Ratio

--

Price = Price / Earnings to growth ratio

loading...

loading...

loading...

Peers

View Details
Company
Price (₹) Market Cap (₹ Cr) Revenue (TTM) Net Profit (TTM) OPM (%) ROE (%) P/E P/B
Brooks Lab
53.4 158.2 88.9 6.5 7.2 20.2 7.3 1.4
2,791.2 34,920.1 5,201.6 1,014.6 22.9 25 34.4 7.6
7,827.5 19,544.3 2,177.5 200.9 11.3 26.5 97.3 23.5
1,565.8 11,917.5 2,089.5 622.0 31.3 20.4 19.4 3.6
1,499.2 9,167.3 1,196.4 149.4 -- 27.5 61.3 13.1
1,332.1 18,429.0 3,078.2 469.4 26.4 14.9 42.7 5.1
1,961.1 31,410.1 4,193.0 753.8 22.7 20.8 41.7 7.8
4,887.1 22,333.8 2,482.3 853.6 33.7 18.9 26.2 5.6
4,778.6 7,918.9 1,348.5 293.5 28.1 50.7 27 11.4
971.2 8,938.5 4,725.6 528.7 14.9 20.7 17.5 3.0

Shareholding Pattern

View Details
loading...

News & Analysis

All News

No Review & Analysis are available.

About Brooks Lab

Brooks Laboratories Limited manufactures and sells pharmaceuticals in India and internationally. The company offers tablets, dry syrup, general injections, liquid injections, dry powder injections, eye/ear drops, nasal drops, oncology products,...  hormonal injections, etc. It also exports its products in Afghanistan, Yemen, Kosovo, Bolivia, Guatemala, Turkmenistan Nigeria, Lebanon, Mauritius, Sudan, Madagascar, DR Congo, Mozambique, LATAM, and Africa. Brooks Laboratories Limited was incorporated in 2002 and is based in Mumbai, India.  Read more

  • Incorporated

    2002

  • Chairman

    --

  • Managing Director

    --

  • Headquarters

    Solan Dist, Himachal Pradesh

  • Website

    www.brookslabs.net

Edit peer-selector-edit

Announcements

View Announcements

FAQs for Brooks Lab

The share price of Brooks Laboratories Ltd is ₹53.38 (NSE) and ₹53.69 (BSE) as of 02-Apr-2026 IST. Brooks Laboratories Ltd has given a return of -4.74% in the last 3 years.

The P/E ratio of Brooks Laboratories Ltd is 7.32 times as on 02-Apr-2026, a 72 discount to its peers’ median range of 26.59 times.
The P/B ratio of Brooks Laboratories Ltd is 1.36 times as on 02-Apr-2026, a 70 discount to its peers’ median range of 4.49 times.


PE & PB ratio at the end of financial year.


Year P/E Ratio P/B Ratio
2025
0.00
3.24
2024
0.00
3.71
2023
0.00
2.09
2022
0.00
2.05
2021
0.00
1.94

The 52-week high and low of Brooks Laboratories Ltd are Rs 164.02 and Rs 36.30 as of 04-Apr-2026.

Brooks Laboratories Ltd has a market capitalisation of ₹ 158 Cr as on 02-Apr-2026. As per SEBI classification, it is a Small Cap company.

Before investing in Brooks Laboratories Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.
Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.